Literature DB >> 19609249

Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009.

.   

Abstract

In April 2009, CDC reported the first two cases in the United States of human infection with a novel influenza A (H1N1) virus. As of July 6, a total of 122 countries had reported 94,512 cases of novel influenza A (H1N1) virus infection, 429 of which were fatal; in the United States, a total of 33,902 cases were reported, 170 of which were fatal. Cases of novel influenza A (H1N1) virus infection have included rapidly progressive lower respiratory tract disease resulting in respiratory failure, development of acute respiratory distress syndrome (ARDS), and prolonged intensive care unit (ICU) admission. Since April 26, communitywide transmission of novel influenza A (H1N1) virus has occurred in Michigan, with 655 probable and confirmed cases reported as of June 18 (Michigan Department of Community Health [MDCH], unpublished data, 2009). This report summarizes the clinical characteristics of a series of 10 patients with novel influenza A (H1N1) virus infection and ARDS at a tertiary-care ICU in Michigan. Of the 10 patients, nine were obese (body mass index [BMI] >or=30), including seven who were extremely obese (BMI =40); five had pulmonary emboli; and nine had multiorgan dysfunction syndrome (MODS). Three patients died. Clinicians should be aware of the potential for severe complications of novel influenza A (H1N1) virus infection, particularly in extremely obese patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609249

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  150 in total

1.  Clinical alert: extracorporeal membrane oxygenation support in management of severe respiratory failure secondary to swine-origin influenza A (H1N1) virus.

Authors:  Chin-Leng Poh; Tristan D Yan
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

2.  The social determinants of health and pandemic H1N1 2009 influenza severity.

Authors:  Elizabeth C Lowcock; Laura C Rosella; Julie Foisy; Allison McGeer; Natasha Crowcroft
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

Review 3.  The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.

Authors:  Carlos del Rio; Jeannette Guarner
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

4.  Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection.

Authors:  C Tsigrelis; M Mohammad; H S Fraimow; R P Dellinger; D Marchesani; A C Reboli
Journal:  Infection       Date:  2010-03-18       Impact factor: 3.553

5.  Models cannot predict future outbreaks: A/H1N1 virus, the paradigm.

Authors:  Antoine Nougairède; Rémi N Charrel; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2010-12-14       Impact factor: 8.082

6.  Chest radiography findings in adults with pandemic H1N1 2009 influenza.

Authors:  R E McEwen; J E Scriven; C A Green; M S Bailey; A K Banerjee
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

7.  Successful management of fulminant influenza A subtype H1N1 myocarditis.

Authors:  Miguel Cobas; Lilian Abbo; Miguel Santos; Clara Baccini-Jauregui; Si Pham
Journal:  BMJ Case Rep       Date:  2010-09-17

8.  Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.

Authors:  Mary S Hayney; Christopher L Coe; Daniel Muller; Chidi N Obasi; Uba Backonja; Tola Ewers; Bruce Barrett
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

Review 9.  2009 H1N1 influenza.

Authors:  Seth J Sullivan; Robert M Jacobson; Walter R Dowdle; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2009-12-10       Impact factor: 7.616

10.  Body mass index is associated with the development of acute respiratory distress syndrome.

Authors:  M N Gong; E K Bajwa; B T Thompson; D C Christiani
Journal:  Thorax       Date:  2009-09-21       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.